Clinical trialPhase 3Completed
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
A Randomized Phase III Study of 5-Fluorouracil-based Regimen With or Without Oxaliplatin as 2nd Line Treatment of Advanced or Metastatic Pancreatic Cancer in Patients Who Have Previously Received Gemcitabine-based Chemotherapy
- Outcome
- Finished, no results posted
- Phase
- Phase 3
- Status
- Completed
- Study type
- Interventional
- Start
- July 2010
- Expected end
- October 2013
- Enrollment
- 108 participants
- Sites
- 15
- Primary outcomes
- Progression-Free Survival (PFS)
- Sponsor
- Industry
- Results posted
- No
- Last update
- 27 October 2014
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try